Nicotine Replacement Therapy in Pregnancy

Introduction to NRT Safety and Efficacy

The American College of Physicians recommends that behavioral counseling should be the first-line treatment for smoking cessation in pregnancy, but if this fails, nicotine replacement therapy (NRT) including the Nicoderm patch may be considered under physician supervision, as NRT is likely safer than continued smoking despite being FDA Pregnancy Category D 1, 2
The American Heart Association suggests that all pregnant women who smoke should receive intensive behavioral counseling as the initial intervention, which increases cessation rates from approximately 11% to 15% 3, 4

Evidence-Based Treatment Algorithm

The American College of Obstetricians and Gynecologists recommends that effective counseling includes messages tailored for pregnancy, information about effects on maternal and fetal health, practical problem-solving skills, and at least 4 sessions with 91-300 minutes total contact time 3, 5
The National Institutes of Health states that behavioral support alone is safe with no adverse events reported in pregnancy 6

Safety Profile of NRT in Pregnancy

The FDA classifies NRT as Pregnancy Category D, meaning there is positive evidence of fetal risk, but potential benefits may warrant use in certain situations 1, 2
The Centers for Disease Control and Prevention notes that NRT is believed to be safer than continued smoking, as cigarette smoke contains thousands of chemicals including documented reproductive toxins like carbon monoxide and lead 1
The American Academy of Pediatrics reports that increased rates of cesarean delivery, slightly increased diastolic blood pressure, skin reactions to the patch, and low-risk cardiovascular events such as tachycardia are associated with NRT use 1, 6

Clinical Efficacy Considerations

The American College of Physicians states that overall evidence on NRT benefit for perinatal and child health outcomes is too limited to draw clear conclusions 1, 2

Practical Recommendations for NRT Use

The National Institutes of Health recommends that if NRT is used, it is imperative to advise strongly that it must be stopped if the mother resumes smoking 7
The American College of Obstetricians and Gynecologists suggests that minimum 12 weeks of therapy for initial quit attempt and schedule follow-up within 2 weeks after starting pharmacotherapy 8
The American Heart Association recommends continuing intensive behavioral counseling throughout NRT use 5

Common Pitfalls to Avoid

The American Academy of Pediatrics advises not to use NRT as first-line treatment without attempting behavioral counseling first 1, 2, 5
The Centers for Disease Control and Prevention notes that the fundamental principle is that smoking during pregnancy causes severe documented harms, and while NRT carries theoretical risks, the balance of evidence suggests NRT is safer than continued smoking 1, 2, 7

Nicotine Replacement Therapy in Pregnancy: Evidence‑Based Recommendations

1. First‑Line Behavioral Counseling

Intensive behavioral counseling should be offered to all pregnant smokers as the initial intervention; it raises late‑pregnancy cessation rates from roughly 11 % to 15 %【9】【10】.
Effective counseling consists of ≥ 4 sessions totaling 91–300 minutes, delivering pregnancy‑specific messages about maternal/fetal health, problem‑solving skills, and strong quit advice【9】.
Counseling alone reduces low‑birth‑weight risk (RR 0.83) and increases mean birth weight by ≈ 56 g, with no reported adverse events【10】.

2. Indications for Nicotine‑Patch Use

For pregnant women with moderate‑to‑high nicotine dependence who have not succeeded with counseling alone, nicotine‑patch therapy may be prescribed under physician supervision after shared decision‑making【11】.

3. Efficacy of Nicotine‑Patch Therapy

Five placebo‑controlled trials show a non‑significant trend toward higher cessation with NRT (11.9 % vs 10.1 %; RR 1.11; 95 % CI 0.79–1.56)【12】【10】.
Adherence to NRT in pregnancy trials is very low (< 10 % in some studies), limiting reliable assessment of both efficacy and safety【10】.

4. Safety Profile of Nicotine Patches

NRT is considered safer than continued smoking because cigarettes deliver thousands of toxic chemicals (e.g., carbon monoxide, lead) whereas patches deliver nicotine only【11】.
Reported adverse events with patches include mildly elevated diastolic blood pressure, skin irritation at the application site, and low‑risk cardiovascular effects such as tachycardia【11】.
Perinatal outcomes associated with NRT are inconsistent and imprecise across the limited trials available【12】【10】.

5. Shared Decision‑Making Discussion Points

Smoking during pregnancy is linked to fetal growth restriction, preterm birth, low birth weight, stillbirth (25‑50 % higher risk), placental complications, and increased perinatal mortality【11】.
Quitting before 15 weeks’ gestation provides the greatest benefit, potentially eliminating adverse effects on fetal growth【13】【11】.
Although NRT efficacy is uncertain, its risk profile is likely more favorable than continued smoking【11】.
The severity of tobacco dependence should be weighed when evaluating risks and benefits of NRT【11】.

6. Contra‑indicated Pharmacotherapies

Bupropion and varenicline are not recommended in pregnancy because no safety or efficacy data exist for these agents【12】【10】.
E‑cigarettes are also not recommended; no trials have evaluated them for cessation in pregnancy, and they contain numerous potentially toxic substances【13】【11】.

Smoking Cessation in Pregnant Women: Evidence‑Based Recommendations

1. First‑Line Intervention – Intensive Behavioral Counseling

The US Preventive Services Task Force (USPSTF) rates intensive behavioral counseling as the only intervention with established safety and effectiveness for pregnant smokers, with high‑certainty evidence that cessation rates rise from ≈ 11 % to 15 % in late pregnancy【14】【15】.
Counseling reduces low‑birth‑weight risk (RR 0.83), increases mean birth weight by ~56 g, and lowers preterm‑birth risk; these fetal benefits have not been demonstrated for pharmacotherapy alone【16】.
No adverse events have been reported for behavioral support in pregnancy, confirming its safety profile【14】.

2. Pharmacotherapy – Nicotine Replacement Therapy (NRT) When Counseling Fails

When intensive counseling alone is insufficient, the USPSTF notes that nicotine gum (intermittent‑dose NRT) is the preferred pharmacologic option, because it delivers nicotine without the thousands of toxic combustion products found in cigarettes【14】【15】【17】.
Evidence from five randomized trials shows modest efficacy of NRT in pregnancy (cessation 11.9 % vs 10.1 % with placebo; RR 1.11, 95 % CI 0.79–1.56), but adherence is very low (<10 %), limiting real‑world effectiveness【16】.
The USPSTF classifies NRT as FDA Pregnancy Category D, indicating evidence of fetal risk; however, the potential benefit of quitting smoking may outweigh this risk when behavioral measures fail【16】.

3. Interventions Lacking Sufficient Evidence – Not Recommended

Bupropion: The USPSTF found zero studies evaluating its benefits or harms for smoking cessation in pregnancy; therefore, it should be avoided due to insufficient safety and efficacy data【14】【17】.
Electronic cigarettes (ENDS): The USPSTF determined inadequate evidence to assess their effect on cessation or safety in pregnant women, with no well‑designed randomized trials available【14】【17】. Consequently, e‑cigarettes are not an acceptable alternative.

4. Practical Implementation Algorithm

4.1 Initiate Intensive Behavioral Counseling Immediately

Deliver at least four counseling sessions (total contact time ≈ 91–300 minutes) over the remaining weeks of pregnancy【18】.
Sessions must include pregnancy‑specific education on maternal and fetal health effects, problem‑solving strategies for trigger identification, and a strong recommendation to quit as soon as possible【18】.

4.2 Assess Nicotine Dependence

For women smoking ≤ 5 cigarettes/day, continue behavioral support alone.
For moderate‑to‑high dependence (> 5 cigarettes/day), consider adding NRT under physician supervision if counseling alone does not achieve cessation.

4.3 Prescribe Nicotine Gum (if NRT Indicated)

Use intermittent‑dose gum to minimize total fetal nicotine exposure compared with continuous‑dose patches.
Advise immediate discontinuation of NRT if the patient resumes smoking, to avoid dual nicotine exposure.
Provide a minimum of 12 weeks of therapy with a follow‑up visit within 2 weeks to monitor adherence and side effects.

4.4 Continue Behavioral Support Throughout NRT Use

Combination of counseling plus NRT is more effective than either alone in non‑pregnant adults, and counseling remains the only proven effective intervention in pregnancy【16】.

5. Risks of Continued Smoking in Pregnancy

The USPSTF reports that continued smoking increases stillbirth risk by 25–50 %, doubles the risk of low birth weight, and contributes to fetal growth restriction, placental abruption, and higher perinatal mortality【14】【15】.